Cargando…
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study
BACKGROUND: Clozapine is the only medication licensed for the treatment of resistant schizophrenia in the UK. Although efficacious, a common and unpopular side effect of clozapine treatment is clozapine-induced hypersalivation (CIH), which can contribute to non-adherence. The standard treatment for...
Autores principales: | Qurashi, Inti, Chu, Simon, Husain, Nusrat, Drake, Richard J., Chaudhry, Imran, Deakin, J. F. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117505/ https://www.ncbi.nlm.nih.gov/pubmed/27871302 http://dx.doi.org/10.1186/s13063-016-1678-5 |
Ejemplares similares
-
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study
por: Qurashi, Inti, et al.
Publicado: (2019) -
A Case of Poisoning by Hyoscin Hydrobromid
Publicado: (1904) -
Clozapine: Drowsiness with markedly increased hypersalivation and myoclonus secondary to clozapine toxicity: case report
Publicado: (2021) -
Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series
por: Takeuchi, Ippei, et al.
Publicado: (2015) -
Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2015)